| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Reference and Education > Financial Aid > Gov Blunt Proposes Need-Based Scholarship Plan for Missouri |
|
E-Articles - Gov Blunt Proposes Need-Based Scholarship Plan for Missouri
About 19,000 more students from Missouri will have access to need-based college scholar According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ships under a new plan advocated by Gov. Matt Blunt. Blunt recommended streamlining th ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in e scholarship application process by combining the current two scholarship programs int lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. o one program called Access Missouri”. He said the new plan will have one simple formul here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe a, and it will be based on a family’s ability to pay for college. Families could consid d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro r a decision about college earlier since they would be able to predict the formula. Cu ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rrently the need-based scholarship programs serve 17,000 students. The "Access Missouri easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi " scholarship program would help fund about 36,000 college students. Under the governo nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically r's plan, which is part of Senate Bill 389, state funding for the higher education scho and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ larship program will be increased to $72.5 from the present $27.5 million. Blunt said ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi he plan is part of an overall effort to increase higher education funding. In addition ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a to increasing scholarship funding, Blunt also called for $40 million in new funding fo dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod r colleges and universities and a three-year plan that increases higher education fundi cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ng in Missouri by more then $110 million. According to Lucas Presson, a southeast stud tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ent from Cape Girardeau, it's often difficult for students to avail of scholarships in t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ubsequent years. Most of the academic scholarships only pay for part of the school cost ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust s; he hoped that need-based scholarships would help fill that gap. The Senate Bill 389 y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products also includes the Lewis and Clark Initiative, which would provide funding of $350 mill . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ion for campus construction projects around the state. Although the democrats have obje elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip cted to the plan, Blunt remains optimistic and hopes the legislature will pass the bill tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Busy Kids Mean Productive Mommies A Re-Think On Guerilla Warfare; Cannot Beat Them, Join Them
|